Skip to main content
Total Market Cap: $48,298,779,128 Volume (24h): $759,890,630

Zynerba Pharmaceuticals Inc.

Zynerba Pharmaceuticals Inc. (ZYNE) logo
Rank 80
About

Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.

Website
$1.1700
USD
-0.81%
Market cap
$27,141,671
Total volume
$467,563
Shares outstanding
23,198,010
Rank 80
Website
About

Zynerba Pharmaceuticals is a biopharmaceutical company that develops transdermal cannabinoid therapies for the treatment of rare diseases. Conditions include Fragile X syndrome, types of epilepsy, and tourettes. Several products are in the preclinical stages of development. Founded in 2007, Zynerba Pharmaceuticals is based in Pennsylvania, US.

Markets
Exchange Symbol Volume (24h) Volume (%) Price
Nasdaq
ZYNE
$467,563
100%
$1.1700
Chart
Social media
Tweets by @ZynerbaPharma

Share widget

Copy widget code
Subscribe to our newsletter